Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Details for Australian Patent Application No. 2005293698 (hide)
International Classifications
Event Publications
31 May 2007 PCT application entered the National Phase
PCT publication WO2006/040182 Priority application(s): WO2006/040182
15 December 2011 Application Accepted
Published as AU-B-2005293698
12 April 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005293702-Gravimetric metering device for bulk products
2005293697-4-phenylsulfonamidopiperidines as calcium channel blockers
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser